7Nutrition Sodium Butyrate Forte 1200 - 60 vege caps
- A high dose of sodium butyrate 1200mg provides 900mg of butyric acid. The enteric HPMC capsule protects the raw material from gastric acid. A formula for those looking after their daily digestive comfort. Supports the function of the intestinal epithelium
Subscription products in your shopping cart
Set one delivery frequency for all subscription products in your cart every:
Subscription products in your shopping cart
7Nutrition Sodium Butyrate Forte 1200 is a modern dietary supplement that provides high-quality sodium butyrate – a stable form of the sodium salt of butyric acid. Butyric acid (butyrate) is one of the most important short-chain fatty acids (SCFA), which is produced naturally in the intestines as a result of fiber fermentation by intestinal bacteria. Its presence in the digestive tract is of great importance for human health – it influences both the functioning of the intestinal epithelium and systemic homeostasis.
The product has been developed for people suffering from digestive disorders, chronic intestinal inflammation, irritable bowel syndrome (IBS), as well as convalescents and those on elimination diets. Due to the use of an enteric-coated capsule (HPMC), the active substance is released only in the further sections of the large intestine, where it is best utilized by epithelial cells. This significantly increases the effectiveness of the supplement and limits the risk of degradation in the higher parts of the digestive system.
The supplement features a clean composition – it is free from allergens, GMOs, gluten, soy, and lactose. The fully plant-based formula makes the product suitable for people on a plant-based diet. The capsule made of hydroxypropyl methylcellulose (HPMC) guarantees safety and convenience of use.
Benefits of using sodium butyrate:
- Energy supply for intestinal epithelial cells (colonocytes).
- Supporting the reconstruction of the intestinal mucosa and the tightness of the intestinal barrier.
- Reducing intestinal permeability and the 'leaky gut' phenomenon.
- Anti-inflammatory effect on a local (intestinal) and systemic level.
- Modulation of the intestinal microbiota by stimulating the growth of beneficial bacteria (e.g., Akkermansia, Faecalibacterium).
- Inhibiting the development of pathogenic bacteria.
- Supporting the treatment of ulcerative colitis and Crohn's disease.
- Reducing IBS symptoms (bloating, abdominal pain, constipation, diarrhea).
- Better intestinal peristalsis – facilitating bowel movements and supporting regularity.
- Indirect influence on brain health and mood (gut-brain axis).
- Reduction of allergy symptoms and food intolerances.
- Supporting immunity through the activation of the GALT system and the production of immunoglobulin A.
- Influence on glucose and lipid metabolism – potential metabolic benefits.
7Nutrition Sodium Butyrate Forte 1200 is recommended for:
- People with irritable bowel syndrome (IBS) and digestive disorders.
- People with inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease.
- People with leaky gut syndrome or food intolerances.
- People after antibiotic therapy, with disrupted intestinal microbiota.
- People struggling with chronic constipation or irregular bowel movement rhythm.
- People on elimination diets, ketogenic diets, SIBO, GAPS.
- Athletes with symptoms of digestive system overload.
- People struggling with acne, eczema, atopy, and other skin symptoms related to the microbiota.
- Older people with reduced SCFA production in the intestines.
The description of the product's action was prepared based on the properties of its ingredients. The content available on the website is for educational purposes and refers to the results of scientific research regarding individual substances. These do not constitute official health claims.
BIBLIOGRAPHY
- Cummings, J. H., et al. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 28(10), 1221–1227.
- Sakata, T. (1987). Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine. British Journal of Nutrition, 58(1), 95–103.
- Scheppach, W., et al. (1992). Effect of short-chain fatty acids on the human colonic mucosa in vitro. JPEN Journal of Parenteral and Enteral Nutrition, 16(1), 43–48.
- Canani, R. B., et al. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12), 1519–1528.
- Hamer, H. M., et al. (2008). Review article: the role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics, 27(2), 104–119.
- Leonel, A. J., & Alvarez-Leite, J. I. (2012). Butyrate: implications for intestinal function. Current Opinion in Clinical Nutrition and Metabolic Care, 15(5), 474–479.
- Parada Venegas, D., et al. (2019). Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, 277.
| Active ingredients: | 1 capsule | 2 capsules |
Sodium butyrate of which butyric acid | 600 mg 450 mg | 1200 mg 900 mg |
Daily serving: 2 capsules
Net weight: 43 g
MANUFACTURER:
7FIT S.A.
Stanowice 82A
55-200 Stanowice